MLH1 Deficiency Enhances Radiosensitization with 5-Fluorodeoxyuridine by Increasing DNA Mismatches

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Pharmacology

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.107.043349PMID 18535288PMCID PMC2615187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A reactive tabu search algorithm for the vehicle routing problem with simultaneous pickups and deliveries

  2008cited by this paper
• Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizers

  2007cited by this paper
• DNA mismatch repair.

  2005cited by this paper
• DNA Mismatch Repair-dependent Response to Fluoropyrimidine-generated Damage*

  2005cited by this paper
• Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cells

  2004cited by this paper
• Thymidylate synthase inhibitors as anticancer agents: from bench to bedside

  2003cited by this paper
• 5-Fluorouracil: mechanisms of action and clinical strategies

  2003cited by this paper
• A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage

  2003cited by this paper
• The role of DNA synthesis inhibition in the cytotoxicity of 2′,2′-difluoro-2′-deoxycytidine

  2003cited by this paper
• Effects of biological DNA precursor pool asymmetry upon accuracy of DNA replication in vitro.

  2002influential reference
• Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.

  2001cited by this paper
• The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.

  2001cited by this paper
• Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen

  2000influential reference
• Lack of Effect of TP53 Status on Fluorodeoxyuridine-Mediated Radiosensitization

  2000cited by this paper
• The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine.

  2000cited by this paper
• Sequence-dependent mutations in a shuttle vector plasmid replicated in a mismatch repair deficient human cell line.

  1999influential reference
• Mismatch repair proficiency and in vitro response to 5-fluorouracil.

  1999influential reference
• Quinol-glutathione conjugate-induced mutation spectra in the supF gene replicated in human AD293 cells and bacterial MBL50 cells.

  1999influential reference
• Resistance to 5-fluorouracil.

  1998cited by this paper
• Comparison of 5-fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer.

  1998cited by this paper
• Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.

  1997cited by this paper
• Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression.

  1996cited by this paper
• Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks

  1996cited by this paper
• Dependence of fluorodeoxyuridine-mediated radiosensitization on S phase progression.

  1995influential reference
• Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death.

  1995cited by this paper
• The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.

  1994cited by this paper
• Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells.

  1994cited by this paper
• The use of biphasic linear ramped pulsed field gel electrophoresis to quantify DNA damage based on fragment size distribution.

  1993cited by this paper
• The effects of dNTP pool imbalances on frameshift fidelity during DNA replication.

  1992cited by this paper
• Radiosensitization by fluorodeoxyuridine: effects of thymidylate synthase inhibition and cell synchronization.

  1992cited by this paper
• Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells.

  1990cited by this paper
• The yield of DNA double-strand breaks produced intracellularly by ionizing radiation: a review.

  1990cited by this paper
• A shuttle vector plasmid for studying carcinogen-induced point mutations in mammalian cells.

  1985cited by this paper
• Mean inactivation dose: a useful concept for intercomparison of human cell survival curves.

  1984cited by this paper
• Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.

  1982influential reference

• Improving radiotherapy in pancreatic cancer through radiosensitization strategies.

  2025cites this paper
• Expressing MLH1 in HCT116 cells increases cellular resistance to radiation by activating the PRKAC

  2021influential citation
• Enhancing treatment response to neo-adjuvant radiation therapy in oesophageal cancer using novel dual action drugs targeting tumour energy metabolism and angiogenesis

  2019cites this paper
• Downregulation of SIRT7 by 5-fluorouracil induces radiosensitivity in human colorectal cancer

  2017cites this paper
• Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine

  2016cites this paper
• Drug Metabolism and Homologous Recombination Repair in Radiosensitization with Gemcitabine

  2015cites this paper
• Defining DNA Double Strand Breaks and the Role of Homologous Recombination in the Mechanism of Radiosensitization by Gemcitabine.

  2013cites this paper
• Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization.

  2012cites this paper
• shRNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization

  2012cites this paper
• Perspectives for tailored chemoprevention and treatment of colorectal cancer in Lynch syndrome.

  2011cites this paper
• Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects.

  2011cites this paper
• APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types regardless of p53 or MMR status

  2009cites this paper
• CHARACTERIZATION OF SYNERGISTIC EFFECT OF IODODEOXYURIDINE AND CLOFARABINE IN CISPLATIN-RESISTANT OVARIAN CANCER CELLS By

  2009cites this paper